InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

68
Insider
Date
Role
Action
Shares
Price
Amount
Christopher Peetz
4 Nov 2026
Chief Executive Officer
Sold after exercise
20,000
$90.00
$1.80M
Jolanda Howe
16 Oct 2026
SVP, Global Controller
Exercised, kept
16,112
$19.24
$309.99K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
6,892
$15.87
$109.38K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
5,305
$19.19
$101.80K
Eric Bjerkholt
14 Sep 2026
Chief Financial Officer
Sell
9,943
$98.37
$978.09K
Jolanda Howe
2 Sep 2026
SVP, Global Controller
Sold on a plan
658
$100.00
$65.80K
Christopher Peetz
1 Sep 2026
Chief Executive Officer
Sold after exercise
21,688
$98.91
$2.15M
Christopher Peetz
1 Sep 2026
Chief Executive Officer
Sold after exercise
8,312
$98.08
$815.24K
Jolanda Howe
18 Aug 2026
SVP, Global Controller
Sold after exercise
40,000
$100.00
$4.00M
Eric Bjerkholt
11 Aug 2026
Chief Financial Officer
Sold on a plan
6,001
$99.90
$599.51K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
2,300
$100.14
$230.32K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
6,017
$99.25
$597.19K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
11,683
$98.51
$1.15M
Jolanda Howe
3 Aug 2026
SVP, Global Controller
Sold on a plan
1,840
$105.29
$193.73K
Eric Bjerkholt
6 Jul 2026
Chief Financial Officer
Sold on a plan
300
$124.94
$37.48K
Eric Bjerkholt
6 Jul 2026
Chief Financial Officer
Sold on a plan
528
$123.84
$65.39K
Eric Bjerkholt
6 Jul 2026
Chief Financial Officer
Sold on a plan
1,048
$122.43
$128.31K
Eric Bjerkholt
6 Jul 2026
Chief Financial Officer
Sold on a plan
3,124
$121.67
$380.10K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
1,710
$124.79
$213.39K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
1,975
$123.74
$244.39K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
4,181
$122.34
$511.50K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
12,134
$121.65
$1.48M
Jolanda Howe
1 Jul 2026
SVP, Global Controller
Sold on a plan
2,721
$120.00
$326.52K
Jolanda Howe
17 Jun 2026
SVP, Global Controller
Sold on a plan
2,594
$101.95
$264.46K
Eric Bjerkholt
9 Jun 2026
Chief Financial Officer
Exercised, kept
2,393
$26.49
$63.39K
Eric Bjerkholt
8 Jun 2026
Chief Financial Officer
Sold on a plan
1,567
$95.12
$149.05K
Eric Bjerkholt
8 Jun 2026
Chief Financial Officer
Sold on a plan
1,175
$93.95
$110.39K
Eric Bjerkholt
8 Jun 2026
Chief Financial Officer
Sold on a plan
2,258
$92.84
$209.63K
Peter Radovich
5 Jun 2026
President and COO
Exercised, kept
16,988
$19.19
$326.00K
Saira Ramasastry
1 Jun 2026
Director
Sell
3,977
$100.00
$397.70K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
883
$99.66
$88.00K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
1,021
$98.20
$100.26K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
1,973
$97.56
$192.49K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
6,926
$96.15
$665.93K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
16,595
$95.34
$1.58M
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
2,602
$94.64
$246.25K
Saira Ramasastry
15 May 2026
Director
Sold after exercise
2,000
$109.47
$218.94K
Saira Ramasastry
15 Apr 2026
Director
Sold after exercise
2,000
$96.90
$193.80K
Christopher Peetz
16 Mar 2026
Chief Executive Officer
Sell
40,985
$91.98
$3.77M
Jolanda Howe
16 Mar 2026
SVP, Global Controller
Sell
4,732
$91.98
$435.24K
Peter Radovich
16 Mar 2026
President and COO
Sell
16,515
$91.98
$1.52M
Saira Ramasastry
16 Mar 2026
Director
Sold after exercise
2,000
$90.76
$181.52K
Joanne Quan
16 Mar 2026
Chief Medical Officer
Sell
7,287
$91.98
$670.24K
Eric Bjerkholt
16 Mar 2026
Chief Financial Officer
Sell
7,287
$91.98
$670.24K
Peter Radovich
6 Mar 2026
President and COO
Exercised, kept
5,912
$15.87
$93.82K
Saira Ramasastry
13 Feb 2026
Director
Sold after exercise
2,000
$102.09
$204.18K
Jolanda Howe
2 Feb 2026
SVP, Global Controller
Sell
968
$103.30
$100.00K
Christopher Peetz
2 Feb 2026
Chief Executive Officer
Sell
9,108
$103.30
$940.89K
Peter Radovich
2 Feb 2026
President and COO
Sell
2,631
$103.30
$271.79K
Christopher Peetz
26 Jan 2026
Chief Executive Officer
Sell
6,831
$96.19
$657.09K
Jolanda Howe
26 Jan 2026
SVP, Global Controller
Sell
842
$96.19
$80.99K
Peter Radovich
26 Jan 2026
President and COO
Sell
3,143
$96.19
$302.33K
Eric Bjerkholt
26 Jan 2026
Chief Financial Officer
Sell
1,053
$96.19
$101.29K
Patrick J Heron
23 Jan 2026
Director
Buy indirect
131,425
$68.48
$9.00M
Christopher Peetz
22 Jan 2026
Chief Executive Officer
Sell
7,098
$93.33
$662.42K
Peter Radovich
22 Jan 2026
President and COO
Sell
2,382
$93.33
$222.30K
Eric Bjerkholt
22 Jan 2026
Chief Financial Officer
Sell
1,421
$93.33
$132.62K
Joanne Quan
22 Jan 2026
Chief Medical Officer
Sell
1,822
$93.33
$170.04K
Jolanda Howe
22 Jan 2026
SVP, Global Controller
Sell
926
$93.33
$86.42K
Joanne Quan
20 Jan 2026
Chief Medical Officer
Sell
6,911
$90.27
$623.85K
Saira Ramasastry
15 Jan 2026
Director
Sold after exercise
2,000
$90.99
$181.98K
Saira Ramasastry
22 Dec 2025
Director
Sold after exercise
5,000
$80.00
$400.00K
Michael G Grey
19 Dec 2025
Director
Sold after exercise
50,000
$78.00
$3.90M
Saira Ramasastry
18 Dec 2025
Director
Sold after exercise
1,000
$70.00
$70.00K
Saira Ramasastry
18 Dec 2025
Director
Sold after exercise
1,000
$69.46
$69.46K
Michael G Grey
1 Dec 2025
Director
Sold after exercise
50,000
$74.00
$3.70M
Michael G Grey
21 Nov 2025
Director
Sold after exercise
50,000
$70.00
$3.50M
Christopher Peetz
18 Nov 2025
Chief Executive Officer
Exercised, kept
19,133
$19.24
$368.12K

What was left out

Form 4 filings counted 67
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 28
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 816,731
History held since 18 Jul 2019